HPV infection has a plausible biological mechanism for triggering autoimmune reactions, but the clinical evidence that it routinely does so in humans is thin and contested. The theoretical link rests on molecular mimicry, where short stretches of HPV proteins closely resemble sequences in human proteins, potentially confusing the immune system into attacking the body’s own tissues. Some epidemiological studies have found associations between HPV infection and conditions like rheumatoid arthritis or lupus, yet disentangling cause from coincidence in these data has proven difficult.
How Molecular Mimicry Creates a Theoretical Risk
The core idea is straightforward: if a virus carries protein fragments that look like pieces of your own cells, the immune response mounted against the virus could accidentally target your tissues too. Researchers have used computer-based analysis to compare HPV protein sequences against the entire catalog of known human proteins, and the overlap is substantial. One analysis found that the immune-reactive portions of HPV’s outer shell protein (called L1) are mostly composed of peptides also found in human proteins, with potential cross-reactivity spanning conditions from ovarian failure to lupus.1PubMed. Human Papillomavirus Epitope Mimicry and Autoimmunity: The Molecular Truth of Peptide Sharing An earlier study examined one of HPV’s cancer-driving proteins (E7) and reached a similar conclusion: the virus shares high and widespread sequence similarity with human proteins involved in critical cellular processes.2PubMed. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences
These computational findings are suggestive, but they come with a major caveat. Short matching sequences between a virus and a human protein do not guarantee that the immune system will actually confuse the two. Sequence alignment studies generate hypotheses, not clinical proof. A critical review of the molecular mimicry literature on HPV found that the key papers had methodological flaws in their methods, results, or discussion sections, and that the hypothesis rested heavily on work from a small number of research groups.3Wiley Online Library. Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine-induced disease So while the biochemistry makes the idea plausible, we are still a long way from proving that HPV infection leads to autoimmune disease through this mechanism in living people.
HPV and Lupus
Of all the autoimmune conditions studied alongside HPV, systemic lupus erythematosus has received the most attention. Multiple studies have found strikingly high HPV infection rates in women with lupus. One Brazilian study found HPV prevalence of about 81% in women with lupus compared with 36% in healthy controls, yielding adjusted odds of over seven times higher for HPV infection in the lupus group.4PubMed. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus Another found a threefold increase in HPV infection among lupus patients despite those patients reporting fewer traditional risk factors for HPV.5PubMed. Are women with lupus at higher risk of HPV infection? A third study documented that over half of lupus patients tested positive for HPV, compared with none among community controls.6PubMed. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients
Here is where interpretation gets tricky. These studies show an association, not a direction of causation. It is entirely possible, and in fact widely suspected, that lupus patients are more susceptible to HPV because their immune systems are already compromised, often further suppressed by immunosuppressive medications. The relationship could also run the other way: persistent HPV infection could contribute to immune dysregulation that eventually tips into autoimmunity. Or both conditions could share a common underlying vulnerability. A computational study specifically investigating the lupus connection found that certain conserved HPV peptides were identical to human peptides implicated in lupus and could bind to lupus-associated immune molecules more avidly than the human versions themselves, which would theoretically give them the ability to provoke an autoimmune reaction.7PubMed. HPV and molecular mimicry in systemic lupus erythematosus and an impact of compiling B-cell epitopes and MHC-class II binding profiles with in silico evidence But this remains a computer-modeled prediction, not a demonstrated clinical pathway.
HPV and Rheumatoid Arthritis
A large cross-sectional analysis using U.S. national survey data found a statistically significant positive association between HPV infection and rheumatoid arthritis in adults aged 18 to 59.8PubMed Central. Association between human papillomavirus infection or immunization and risk for rheumatoid arthritis The same study found something perhaps more interesting: HPV vaccination was associated with substantially lower odds of rheumatoid arthritis prevalence. The finding held after adjusting for age, sex, race, smoking, diabetes, and other potential confounders.
This creates a paradox worth sitting with. If HPV infection is associated with more rheumatoid arthritis and HPV vaccination with less, the implication is that preventing HPV infection might reduce autoimmune risk rather than increase it. That would support the idea that the virus itself, not the vaccine, is the relevant trigger. But cross-sectional data can only show a snapshot in time, not prove that infection preceded the arthritis. People who get vaccinated early in life may differ from those who do not in ways that go beyond HPV status alone.
Do HPV Vaccines Increase Autoimmune Risk?
This is the question that has driven the most research and the most public anxiety. The short answer from multiple large studies and meta-analyses is: no, not in any consistent or clinically meaningful way.
The largest systematic review and meta-analysis on the topic, published in 2025 and covering over eight million patients, found no increased autoimmune risk among HPV vaccine recipients, with a combined relative risk of 0.76.9PubMed Central. No Increased Risk of Autoimmune Diseases Following HPV Vaccination: A Systematic Review and Meta-Analysis An earlier meta-analysis looking at the same question also found no correlation, with a pooled odds ratio of about 1.04.10PubMed Central. HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature A third meta-analysis examining 22 studies and 48 disease-specific pooled risk estimates found no significant association for the vast majority of conditions studied.11The Pediatric Infectious Disease Journal. Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events A study specifically in boys found autoimmune disease rates essentially identical between vaccinated and unvaccinated groups.12International Journal of Epidemiology. Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism
There are two areas where the data is less clean. A large Scandinavian cohort study of over three million women initially flagged several autoimmune conditions as potentially elevated after vaccination, including Hashimoto’s thyroiditis, celiac disease, and localized lupus. After accounting for the statistical problem of testing many diseases at once, only celiac disease remained, with a relative risk of about 1.56.13PubMed. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases Whether this represents a true biological effect or a residual statistical artifact remains debated.
The Guillain-Barré Signal
Guillain-Barré syndrome, a rare condition in which the immune system attacks peripheral nerves, has received special attention because a signal appeared in one large French cohort. That study of over two million young girls found an elevated rate of Guillain-Barré after HPV vaccination, estimating that if the link were causal, it would produce one to two extra cases per 100,000 girls vaccinated.14PubMed. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France A meta-analysis pooling the broader literature, however, found a pooled risk estimate of about 1.21 that was not statistically significant, with high variability between studies and very low quality of evidence overall. That translates to roughly one hypothetical case per million vaccinations.15PubMed Central. Risk of Guillain–Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020 Guillain-Barré has been weakly associated with several other vaccines too, and the absolute risk, if it exists at all, is vanishingly small.
Post-Vaccination Symptoms and the ASIA Hypothesis
Some researchers have proposed a broader syndrome called “Autoimmune/Inflammatory Syndrome Induced by Adjuvants,” or ASIA, which suggests that immune-stimulating ingredients in vaccines can trigger autoimmune phenomena in susceptible people. An analysis of adverse event reports estimated a reporting rate of about 3.6 cases per 100,000 HPV vaccine doses distributed.16PubMed. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems The most commonly reported symptoms were fever, muscle pain, and joint pain or arthritis. The concept has continued to evolve, with more recent reviews describing new adjuvant- and vaccine-related triggers.17PubMed. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023
Case series from several countries have described clusters of symptoms appearing after HPV vaccination, including disabling fatigue, widespread pain, fainting, digestive problems, and cognitive difficulties. These have been labeled variously as complex regional pain syndrome, postural orthostatic tachycardia syndrome, small fiber neuropathy, or chronic fatigue syndrome.18PubMed. Autonomic dysfunction and HPV immunization: an overview Individual case reports have described conditions like postural orthostatic tachycardia developing within months of vaccination.19PubMed Central. Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the “Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants”
The ASIA concept is controversial within mainstream immunology. The key difficulty is that these symptoms are common in the general population, especially among adolescents and young adults, which makes it hard to determine whether cases appearing after vaccination are caused by the vaccine or would have occurred anyway. Adverse event reporting systems capture temporal associations, not proven causal relationships. A Japanese study specifically tested whether “healthy vaccinee bias” might be distorting the data from the large Nagoya study of HPV vaccine symptoms and found that such bias was limited, meaning it could not explain away the reported symptom patterns.20PubMed. A large epidemiological study on human papillomavirus vaccine post-vaccination symptoms and healthy vaccinee bias Still, most regulatory bodies and expert panels have concluded that the overall evidence does not support a causal link between HPV vaccination and autoimmune disease at a population level.
Why Sex and Hormones May Matter
Autoimmune diseases disproportionately affect women, and HPV is a sexually transmitted infection with high prevalence in both sexes. This intersection matters when evaluating any possible HPV-autoimmune link. Sex hormones like estrogen promote B-cell activation, antibody production, and particular immune response patterns that, while making the immune system more effective against infections, may also make it more prone to turning on itself.21Journal of Translational Autoimmunity. Immune responses to infection and autoimmune diseases in the UK biobank This means that infections in general, including HPV, could more easily precipitate autoimmune reactions in women than in men. The phenomenon is not specific to HPV; it is a feature of female immunology that affects how the body responds to many different microbial triggers.
This also complicates the study of HPV vaccines, which were initially rolled out primarily to girls and young women. The population most intensively vaccinated happened to be the population most prone to developing autoimmune conditions in that age range regardless of vaccination status. Detecting a small vaccine-attributable risk against this high background rate requires enormous sample sizes and careful statistical design, which is why the most informative studies on the topic involve millions of participants.
Getting Vaccinated When You Already Have an Autoimmune Disease
If you have lupus, rheumatoid arthritis, or another autoimmune condition, you might wonder whether getting the HPV vaccine could make things worse. The evidence here is more reassuring than many patients and even some clinicians expect. A systematic review of HPV vaccine studies in people with autoimmune diseases found that the vaccines were effective and safe in most patients, though questions remain about whether concurrent immunosuppressive therapies might reduce the vaccine’s effectiveness.22PubMed. Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review A controlled study specifically in lupus patients found that the quadrivalent HPV vaccine was well tolerated and did not increase disease activity or trigger flares in people with stable lupus.23Annals of the Rheumatic Diseases. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study
There is actually a stronger case for vaccinating people with autoimmune diseases than for avoiding it. Because immunosuppressive treatments make these patients more vulnerable to persistent HPV infection, and persistent HPV drives cervical and other cancers, unvaccinated autoimmune patients face a compounded risk. The elevated HPV infection rates documented in lupus patients underscore this point. Expert reviewers have argued that HPV vaccine uptake should be specifically encouraged in autoimmune populations, given the evidence of safety and the heightened risk of HPV-related complications.24PubMed Central. Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?
How HPV Vaccine Adjuvants Work
Some of the concern about vaccines and autoimmunity centers on adjuvants, the immune-boosting ingredients added to vaccines to make them more effective. One HPV vaccine (Cervarix) uses an adjuvant system called AS04, which combines an aluminum salt with a compound that activates a specific receptor on immune cells. This combination triggers a brief, localized burst of immune signaling at the injection site, which increases the number of activated immune cells carrying vaccine information to nearby lymph nodes and amplifies the immune response.25The Journal of Immunology. AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity The immune activation is transient and confined to the injection area, and the adjuvant and the antigen need to be present at the same site within 24 hours of each other for the effect to work.26PubMed. Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach
The transient nature of this immune activation is part of why most researchers are skeptical that adjuvants alone could reliably trigger lasting autoimmune disease. A brief local inflammatory response is exactly what adjuvants are designed to produce, and that response resolves. The hypothesis that this short burst could somehow permanently redirect the immune system toward self-attack requires additional steps, such as genetic predisposition or preexisting subclinical autoimmunity, that have not been consistently demonstrated in large human studies. Aluminum-containing adjuvants have been used in vaccines for decades across billions of doses, which provides a substantial safety track record even if individual case reports and small series continue to raise questions.
Microbiome Changes After HPV Infection
An emerging area of research examines how HPV infection reshapes the microbial communities of the urogenital tract. HPV infection alters the bacterial composition of the cervix, vagina, and urethra, with certain bacterial genera, including Lactobacillus and Corynebacterium, responding to HPV infection across multiple body sites.27Journal of Translational Medicine. Changes in microbial composition and interaction patterns of female urogenital tract and rectum in response to HPV infection There appears to be a strong microbial interaction network between the cervix, vagina, and urethra, and the interplay between inflammatory signals and different bacterial groups may itself influence how the immune system responds to HPV.
This matters for the autoimmune question because the microbiome is increasingly recognized as a regulator of immune tolerance, the immune system’s ability to distinguish self from non-self. Disruptions to the microbiome have been linked to autoimmune diseases through separate lines of research. Whether HPV-driven microbiome changes could contribute to autoimmune vulnerability is speculative at this stage, but it represents a pathway that future research may clarify. It also means that the relationship between HPV and the immune system extends well beyond what the virus’s proteins do directly.